ReviewFrontiers in microbiology2025
Heterologous production of caffeic acid in microbial hosts: current status and perspectives.
Review in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent advances in Polygonaceae endophytes: diversity, secondary metabolites and biotechnological applications.Frontiers in bioengineering and biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Caffeic acid, a plant-derived phenolic compound, has attracted much attention in the fields of medicines and cosmetics due to its remarkable physiological activities including antioxidant, anti-inflammation, antibacteria, antivirus and hemostasis. However, traditional plant extraction and chemical synthesis methods exist some problems such as high production costs, low extraction efficiency and environmental pollution. In recent years, the construction of microbial cell factories for the biosynthesis of caffeic acid has attracted much attention due to its potential to offer an efficient and environmentally-friendly alternative for caffeic acid production. This review introduces the caffeic acid biosynthesis pathway first, after which the characteristics of microbial hosts for caffeic acid production are analyzed. Then, the main strategies for caffeic acid production in microbial hosts, including selection and optimization of heterologous enzymes, enhancement of the metabolic flux to caffeic acid, supply and recycling of cofactor, and optimization of the production process, are summarized and discussed. Finally, the future prospects and perspectives of microbial caffeic acid production are discussed. Recent breakthroughs have achieved caffeic acid titers of up to 6.17 g/L, demonstrating the potential of microbial biosynthesis. Future research can focus on the enhancement of metabolic flux to caffeic acid biosynthesis pathway, the development of robust microbial hosts with improved tolerance to caffeic acid and its precursors, and the establishment of cost-effective industrial production processes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.